Literature DB >> 16022753

Glucagon-like peptide-1 release and satiety after a nutrient challenge in normal-weight and obese subjects.

Tanja C M Adam1, Margriet S Westerterp-Plantenga.   

Abstract

The present study was conducted to assess whether glucagon-like peptide-1 (GLP-1) release and appetite after a breakfast with or without an additional galactose/guar gum stimulation is different in normal-weight compared with overweight/obese subjects. Twenty-eight overweight/obese (BMI 30.3 (sd 2.7) kg/m2; age 44.3 (sd 9.7) years) and thirty normal-weight subjects (BMI 22.8 (sd 1.4), age 31.5 (sd12.8) years) participated in a crossover study. Fasting and postprandial plasma GLP-1, insulin, glucose and free fatty acid concentrations were measured in response to either a galactose (50 g)/guar gum (2.5 g) load (836 kJ) and a standard breakfast (1.9 MJ; GG), or water (250 ml) and the standard breakfast (W) every 30 min relative to the ingestion for 120 min. Appetite was assessed using 100 mm visual analogue scales. GLP-1 concentrations were significantly increased after GG at 30 and 60 min compared with W in both groups. Plasma GLP-1 concentrations in the W condition were higher in normal-weight than overweight/obese subjects (P=0.03). No difference was observed in the GG condition between groups. Satiety was increased in normal-weight compared with overweight/obese subjects in the GG condition at 30 (P=0.02) and 60 (P=0.04) min. We conclude that after a standard breakfast with water, GLP-1 release was lower in the overweight/obese than the normal-weight subjects. However, postprandial GLP-1 release in overweight/obese subjects was no different from that of normal-weight subjects when galactose/guar gum was added to the breakfast. The latter was not mirrored by subjective feelings of satiety. Disturbed perception of the physiological feedback of a satiety hormone rather than disturbed feedback itself might contribute to obesity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16022753     DOI: 10.1079/bjn20041335

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  30 in total

Review 1.  Intestinal GLP-1 and satiation: from man to rodents and back.

Authors:  R E Steinert; C Beglinger; W Langhans
Journal:  Int J Obes (Lond)       Date:  2015-08-28       Impact factor: 5.095

2.  Using pre-prandial blood glucose to assess eating in the absence of hunger in free-living individuals.

Authors:  Susan M Schembre; Yue Liao; Jimi Huh; Stefan Keller
Journal:  Eat Behav       Date:  2020-07-09

3.  Two weeks of exercise training intensity on appetite regulation in obese adults with prediabetes.

Authors:  Emily M Heiston; Natalie Z M Eichner; Nicole M Gilbertson; Julian M Gaitán; Sibylle Kranz; Arthur Weltman; Steven K Malin
Journal:  J Appl Physiol (1985)       Date:  2019-01-10

4.  Cardiovascular responses to sugary drinks in humans: galactose presents milder cardiac effects than glucose or fructose.

Authors:  Nathalie Charrière; Cathriona Loonam; Jean-Pierre Montani; Abdul G Dulloo; Erik K Grasser
Journal:  Eur J Nutr       Date:  2016-06-21       Impact factor: 5.614

5.  GLP-1 analogue liraglutide as adjunct treatment in diabetes type 2 after failed bariatric/metabolic surgery.

Authors:  Per M Hellström
Journal:  Ann Transl Med       Date:  2019-09

Review 6.  Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.

Authors:  Robert E Steinert; Christine Feinle-Bisset; Lori Asarian; Michael Horowitz; Christoph Beglinger; Nori Geary
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

7.  Use of cereal fiber to facilitate adherence to a human caloric restriction program.

Authors:  Cheryl H Gilhooly; Sai Krupa Das; Julie K Golden; Megan A McCrory; James Rochon; James P DeLany; Alicia M Freed; Paul J Fuss; Gerard E Dallal; Edward Saltzman; Susan B Roberts
Journal:  Aging Clin Exp Res       Date:  2008-12       Impact factor: 3.636

Review 8.  Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence.

Authors:  Radica Z Alicic; Emily J Cox; Joshua J Neumiller; Katherine R Tuttle
Journal:  Nat Rev Nephrol       Date:  2020-11-20       Impact factor: 28.314

9.  Effect of alginate on satiation, appetite, gastric function, and selected gut satiety hormones in overweight and obesity.

Authors:  Suwebatu T Odunsi; María I Vázquez-Roque; Michael Camilleri; Athanasios Papathanasopoulos; Matthew M Clark; Lynne Wodrich; Mary Lempke; Sanna McKinzie; Michael Ryks; Duane Burton; Alan R Zinsmeister
Journal:  Obesity (Silver Spring)       Date:  2009-12-03       Impact factor: 5.002

10.  Effect of valproic acid on body weight, food intake, physical activity and hormones: results of a randomized controlled trial.

Authors:  C K Martin; H Han; S D Anton; F L Greenway; S R Smith
Journal:  J Psychopharmacol       Date:  2008-06-26       Impact factor: 4.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.